Message from the Office of Developmental Programs (ODP):
As a result of the COVID-19 pandemic, the Office of Developmental Programs (ODP) received approval from the Centers for Medicare and Medicaid Services (CMS) to delay the Quality Assessment and Improvement (QA&I) activities associated to Cycle 2, Year 1 until July 1, 2022. For FY 2021–2022, ODP will be conducting a second interim review process with several temporarily modified QA&I activities of Administrative Entities (AE), Supports Coordination Organizations (SCO), and Providers; which includes Agency with Choice (AWC) Financial Management Services (FMS) Providers.
The QA&I Interim Year 2 review process is used to demonstrate outcomes in the following areas: CMS Performance Measures, Information Sharing Advisory Committee (ISAC) recommendations, health and welfare, and ODP priorities. It also serves to validate an entity’s adherence with federal and state requirements.
During Interim Year 2, AEs, SCOs and Providers identified in the sample will not receive a traditional onsite review as all activities will occur remotely to include a virtual conference and virtual follow-up meetings if necessary.
Attached please find the updated QA&I Interim Year 2 Review Process Document that includes the changes highlighted in yellow. This document will provide important information for stakeholders to complete the process successfully.
ODP recognizes the many ongoing challenges providers, SCOs, and AEs are managing related to the COVID-19 pandemic; thank you for your continued commitment to supporting individuals with and intellectual disability and autism.